GlaxoSmithKline PLC — Director's Dealing 2015

Feb 19, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4135F

GlaxoSmithKline PLC

19 February 2015

Notification of Transactions of Directors and Persons Discharging Managerial   Responsibility

GlaxoSmithKline Share Value Plan

Sale of shares to meet tax liabilities

The table below sets out changes in the interests of Persons Discharging Managerial Responsibility (PDMR) in the Ordinary Shares of GlaxoSmithKline plc arising from the sales of Ordinary Shares at a fair market value price of £15.353625 per Ordinary Share on 18 February 2015.  These sales were to meet tax liabilities following the vesting of awards granted in 2012 under the GlaxoSmithKline Share Value Plan (SVP).

	Number of Ordinary Shares sold to meet tax liabilities following the vesting of a SVP award
Mr R Connor	8,423
Mrs V Whyte	6,143

The table below sets out changes in the interests of a PDMR in the American Depositary Shares (ADS) of GlaxoSmithKline plc arising from the withholding of ADS at a fair market value price of $47.94 per ADS on 18 February 2015 to meet tax liabilities following the vesting of awards granted in 2012 under the SVP.

	Number of ADSs withheld to meet tax liabilities following the vesting of a SVP award
Mr N Hirons	1,891

The Company and PDMRs were advised of these transactions on 19 February 2015.      

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

19 February 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSVKLFFELFBBBD